We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Circassia Group Plc | LSE:CIR | London | Ordinary Share | GB00BJVD3B28 | ORD 0.08P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 34.00 | 33.10 | 34.90 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCIR
RNS Number : 1186I
Circassia Pharmaceuticals Plc
31 March 2020
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
(Note: Italicised terms have the same meaning as given in the Listing Rules.)
Date: 31(st) March 2020
Name of applicant: Circassia Pharmaceuticals plc Name of scheme: Circassia EMI Share Option Scheme ---------------------------------------------- Period of return: From: 1(st) October 2019 To: 31(st) March 2020 ----------------------- ------------------- ----- ------------------ Balance of unallotted securities under scheme(s) from previous return: 700,750 ---------------------------------------------- Plus: The amount by which the block scheme(s) has been increased - since the date of the last return (if any increase has been applied for): ---------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during - period (see LR3.5.7G): ---------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 700,750 ---------------------------------------------- Name of applicant: Circassia Pharmaceuticals plc Name of scheme: Circassia 2007 Unapproved Share Scheme ---------------------------------------------- Period of return: From: 1(st) October 2019 To: 31(st) March 2020 ----------------------- ------------------- ----- ------------------ Balance of unallotted securities under scheme(s) from previous return: 203,000 ---------------------------------------------- Plus: The amount by which the block scheme(s) has been increased - since the date of the last return (if any increase has been applied for): ---------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during - period (see LR3.5.7G): ---------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 203,000 ---------------------------------------------- Name of applicant: Circassia Pharmaceuticals plc Name of scheme: Circassia 2014 Performance Share Plan Scheme ------------------------------------------------- Period of return: From: 1(st) October 2019 To: 31(st) March 2020 ----------------------- --------------------- ----- ------------------- Balance of unallotted securities under scheme(s) from previous return: 76,676 ------------------------------------------------- Plus: The amount by which the block scheme(s) has been increased - since the date of the last return (if any increase has been applied for): ------------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during - period (see LR3.5.7G): ------------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 76,676 ------------------------------------------------- Name of applicant: Circassia Pharmaceuticals plc Name of scheme: Circassia 2015 Performance Share Plan Scheme ------------------------------------------------- Period of return: From: 1(st) October 2019 To: 31(st) March 2020 ----------------------- --------------------- ----- ------------------- Balance of unallotted securities under scheme(s) from previous return: 280,612 ------------------------------------------------- Plus: The amount by which the block scheme(s) has been increased - since the date of the last return (if any increase has been applied for): ------------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): (4,442) ------------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 276,170 ------------------------------------------------- Name of applicant: Circassia Pharmaceuticals plc Name of scheme: Circassia 2016 Performance Share Plan Scheme ------------------------------------------------- Period of return: From: 1(st) October 2019 To: 31(st) March 2020 ----------------------- --------------------- ----- ------------------- Balance of unallotted securities under scheme(s) from previous return: 812,071 ------------------------------------------------- Plus: The amount by which the block scheme(s) has been increased - since the date of the last return (if any increase has been applied for): ------------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): (26,902) ------------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 785,169 ------------------------------------------------- Name of contact: Michael Roller Telephone number of contact: 01865 405 560 ---------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BLRWPUCGWUPUGQU
(END) Dow Jones Newswires
March 31, 2020 02:00 ET (06:00 GMT)
1 Year Circassia Chart |
1 Month Circassia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions